Evolent Health, Inc. 4
4 · Evolent Health, Inc. · Filed Jun 8, 2017
Insider Transaction Report
Form 4
WIGGINTON STEVE
Chief Development Officer
Transactions
- Sale
Class A Common Stock
2017-06-06$25.75/sh−959$24,694→ 12,411 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2016.
- [F2]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.